Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Ciurea

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Scientific Reports|July 26, 2018
Evaluating the bromodomain protein BRD1 as a therapeutic target in rheumatoid arthritisKerstin Klein, Masaru Kato, Mojca Frank-Bertoncelj, et al.
Journal of Ultrasonography|December 18, 2015
Correlation of findings in clinical and high resolution ultrasonography examinations of the painful shoulderRaphael Micheroli, Diego Kyburz, Adrian Ciurea, et al.
Joint Bone Spine|November 21, 2012
BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatmentFabienne Niederer, Almut Scherer, Diego Kyburz, et al.
Nature Immunology|March 11, 2003
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infectionsLukas Hunziker, Mike Recher, Andrew J Macpherson, et al.
Rheumatology International|July 30, 2014
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteriaPascal Zufferey, Jacqueline Ghosn, Fabio Becce, et al.
The Journal of Experimental Medicine|October 23, 2002
Antagonistic variant virus prevents wild-type virus-induced lethal immunopathologyLukas Hunziker, Mike Recher, Adrian Ciurea, et al.
Arthritis Research & Therapy|March 23, 2016
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management CohortAdrian Ciurea, Pascale Exer, Ulrich Weber, et al.
Plos One|May 1, 2019
The appearance of joint manifestations in the Swiss inflammatory bowel disease cohortAimee Hiller, Luc Biedermann, Nicolas Fournier, et al.
Arthritis Research & Therapy|September 29, 2023
Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL StartAdrian Ciurea, Oliver Distler, Kenneth Kwok, et al.
Arthritis Care & Research|July 10, 2013
Effect of cardiovascular training on fitness and perceived disease activity in people with ankylosing spondylitisKarin Niedermann, Eduard Sidelnikov, Claudia Muggli, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Scientific Reports|July 26, 2018
Evaluating the bromodomain protein BRD1 as a therapeutic target in rheumatoid arthritisKerstin Klein, Masaru Kato, Mojca Frank-Bertoncelj, et al.
Journal of Ultrasonography|December 18, 2015
Correlation of findings in clinical and high resolution ultrasonography examinations of the painful shoulderRaphael Micheroli, Diego Kyburz, Adrian Ciurea, et al.
Joint Bone Spine|November 21, 2012
BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatmentFabienne Niederer, Almut Scherer, Diego Kyburz, et al.
Nature Immunology|March 11, 2003
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infectionsLukas Hunziker, Mike Recher, Andrew J Macpherson, et al.
Rheumatology International|July 30, 2014
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteriaPascal Zufferey, Jacqueline Ghosn, Fabio Becce, et al.
The Journal of Experimental Medicine|October 23, 2002
Antagonistic variant virus prevents wild-type virus-induced lethal immunopathologyLukas Hunziker, Mike Recher, Adrian Ciurea, et al.
Arthritis Research & Therapy|March 23, 2016
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management CohortAdrian Ciurea, Pascale Exer, Ulrich Weber, et al.
Plos One|May 1, 2019
The appearance of joint manifestations in the Swiss inflammatory bowel disease cohortAimee Hiller, Luc Biedermann, Nicolas Fournier, et al.
Arthritis Research & Therapy|September 29, 2023
Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL StartAdrian Ciurea, Oliver Distler, Kenneth Kwok, et al.
Arthritis Care & Research|July 10, 2013
Effect of cardiovascular training on fitness and perceived disease activity in people with ankylosing spondylitisKarin Niedermann, Eduard Sidelnikov, Claudia Muggli, et al.
Pageof 13